Evolving Topics in Cancer Immunotherapy
A joint workshop at Melanoma Bridge 2016
December 1, 2016 – Naples, Italy
Immunotherapy Bridge • November 30, 2016
Melanoma Bridge • December 1 - 3, 2016
Royal Continental Hotel • Naples, Italy
Presented by Fondazione Melanoma Onlus in collaboration with the IRCCS Fondazione G. Pascale National Cancer Institute, Sidra Medical and Research Center, the Italian Association of Medical Oncology, and the Society for Immunotherapy of Cancer
Immunotherapy Bridge
The second annual Immunotherapy Bridge preceded Melanoma Bridge 2016. This scientific program focused on the application of immunotherapy experience with melanoma to other tumor types and on the interpretation of data from clinical trials.
Attendees were expected from all around the world and were encouraged to submit their abstracts for poster or oral presentations during the event. All accepted abstracts were included in a scientific journal. The speaker of the abstracts selected for oral communication were exempt from the registration fee and were invited as speakers to Naples.
Melanoma Bridge 2016
With an internationally acknowledged scientific board, the meeting was organized in the following sessions:
- Evolving Topics in Cancer Immunotherapy
- World-Wide Immunoscore Task Force
- System Biology Session: Molecular
- Combination Strategy Session
- System Biology Session: Immunology
- Biomarkers Session
New this year, SITC collaborated on a joint session at Melanoma Bridge 2016 on Thursday, December 1 on Evolving Topics in Cancer Immunotherapy:
Coordinators
Paolo A. Ascierto, MD - Istituto Nazionale Tumori - IRCCS "Fondazione G. Pascale"
Sandra Demaria, MD - Weill Cornell Medical College
Giuseppe Masucci, MD, PhD - Karolinska Institutet
Magdalena Thurin, PhD - National Cancer Institute of the National Institutes for Health, U.S. Department of Health & Human Services |
| |
|
| 9:30 - 9:50 a.m. |
Treatment-induced molecular pathways regulate the immunogenicity of radiotherapy
Sandra Demaria, MD - Weill Cornell Medical College
|
| 9:50 - 10:10 a.m. |
In Situ Tumor Vaccination Using Local Radiotherapy and Intratumoral Immunocytocine
Paul M. Sondel, MD, PhD - University of Wisconsin - Madison
|
| 10:10 - 10:30 a.m. |
Cancer Vaccines in the Era of Checkpoint Blockade
Willem W. Overwijk, PhD - University of Texas MD Anderson Cancer Center
|
| 10:30 - 10:50 a.m. |
Therapy of Solid Cancers Using T Cells and Running Shoes
Per thor Straten - University of Copenhagen Harlev Hospital
|
| 10:50 - 11:05 a.m. |
Break
|
| 11:05 a.m. - 12:05 p.m. |
Oral communications
|
| 12:05 - 1:05 p.m. |
Sponsored Symposium
|
| 1:05 -1:20 p.m. |
Conclusions
Session Coordinators |
For more information on either program, visit www.melanomabridge.org.